Aberdeen Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$170M Buy
620,828
+9,594
+2% +$2.62M 0.29% 67
2025
Q1
$161M Sell
611,234
-20,287
-3% -$5.33M 0.31% 61
2024
Q4
$146M Sell
631,521
-19,152
-3% -$4.44M 0.27% 72
2024
Q3
$142M Sell
650,673
-9,686
-1% -$2.12M 0.26% 87
2024
Q2
$130M Sell
660,359
-60,292
-8% -$11.9M 0.25% 86
2024
Q1
$155M Buy
720,651
+27,071
+4% +$5.83M 0.3% 68
2023
Q4
$146M Buy
693,580
+93,713
+16% +$19.7M 0.32% 69
2023
Q3
$120M Sell
599,867
-31,830
-5% -$6.37M 0.31% 79
2023
Q2
$117M Sell
631,697
-5,062
-0.8% -$938K 0.27% 89
2023
Q1
$122M Buy
636,759
+88,327
+16% +$16.9M 0.31% 76
2022
Q4
$92.2M Sell
548,432
-32,532
-6% -$5.47M 0.25% 91
2022
Q3
$103M Buy
580,964
+43,950
+8% +$7.78M 0.31% 75
2022
Q2
$110M Buy
537,014
+2,963
+0.6% +$605K 0.34% 71
2022
Q1
$130M Sell
534,051
-234,948
-31% -$57.2M 0.33% 74
2021
Q4
$176M Sell
768,999
-57,076
-7% -$13M 0.39% 65
2021
Q3
$161M Buy
826,075
+9,293
+1% +$1.81M 0.36% 72
2021
Q2
$174M Buy
816,782
+72,908
+10% +$15.5M 0.38% 64
2021
Q1
$152M Sell
743,874
-287,099
-28% -$58.6M 0.35% 75
2020
Q4
$188M Sell
1,030,973
-31,525
-3% -$5.74M 0.46% 58
2020
Q3
$178M Sell
1,062,498
-26,738
-2% -$4.47M 0.47% 55
2020
Q2
$177M Buy
1,089,236
+76,788
+8% +$12.5M 0.48% 57
2020
Q1
$175M Sell
1,012,448
-120,861
-11% -$20.9M 0.56% 46
2019
Q4
$227M Sell
1,133,309
-356,727
-24% -$71.6M 0.55% 47
2019
Q3
$315M Sell
1,490,036
-278,371
-16% -$58.8M 0.79% 28
2019
Q2
$343M Buy
1,768,407
+566,581
+47% +$110M 0.76% 30
2019
Q1
$198M Sell
1,201,826
-255,180
-18% -$42M 0.43% 63
2018
Q4
$269M Sell
1,457,006
-247,005
-14% -$45.6M 0.64% 41
2018
Q3
$290M Sell
1,704,011
-61,918
-4% -$10.5M 0.54% 48
2018
Q2
$289M Buy
1,765,929
+487,442
+38% +$79.9M 0.56% 47
2018
Q1
$207M Buy
1,278,487
+11,382
+0.9% +$1.84M 0.41% 63
2017
Q4
$185M Sell
1,267,105
-298,440
-19% -$43.6M 0.35% 76
2017
Q3
$212M Buy
+1,565,545
New +$212M 0.39% 68